Nox Health Acquires Somryst from Pear Therapeutics
May 25, 2023
Nox Health, a global sleep health company based in Alpharetta, Georgia, has acquired Somryst—the FDA-cleared prescription digital therapeutic for chronic insomnia—purchased from Pear Therapeutics. The acquisition brings an outcomes-validated insomnia treatment into Nox's value-based sleep care programs to expand its clinical offerings for employers, health plans and health systems.
- Buyers
- Nox Health
- Targets
- Somryst
- Sellers
- Pear Therapeutics
- Industry
- Healthcare Services
- Location
- Massachusetts, United States
- Transaction Type
- Divestiture
Explore More
Related Acquisitions
-
XRHealth Acquires Swing Therapeutics to Expand Into Mobile and FDA-Authorized Digital Therapeutics
July 15, 2026
Healthcare Services
XRHealth announced it has acquired Swing Therapeutics to expand its AI-powered digital health platform from extended reality (XR) into mobile apps, wearables, and other connected devices. The deal adds Swing’s FDA De Novo–authorized Stanza digital behavioral therapy and the Swing Care virtual specialty clinic for chronic pain and fibromyalgia, creating a more comprehensive reimbursable care platform.
-
ResMed Completes Acquisition of Noctrix Health for $340 Million
June 1, 2026
Medical Devices
ResMed completed its acquisition of Noctrix Health, a medical device company developing wearable therapeutics for chronic neurological disorders. The deal expands ResMed’s clinical sleep health portfolio with Noctrix’s Nidra Tonic Motor Activation (TOMAC) therapy for moderate-to-severe Restless Legs Syndrome (RLS), with Noctrix becoming a wholly owned subsidiary. The acquisition was previously announced as a definitive merger agreement to acquire Noctrix for $340 million, expected to close on or around June 1, 2026.
-
Sunrise Acquires Dreem Health to Expand U.S. Sleep Care Presence
December 12, 2024
Healthcare Services
Belgium-based sleep diagnostics company Sunrise has acquired California-based virtual sleep clinic Dreem Health to accelerate its U.S. expansion and add telehealth diagnosis and treatment capabilities. By pairing Sunrise's at-home sleep testing technology with Dreem Health's licensed providers and insurer partnerships, Sunrise aims to scale nationwide access to sleep care.
-
ResMed Acquires Somnoware
July 5, 2023
Healthcare Services
ResMed has acquired privately held Somnoware, a U.S.-based provider of cloud-based sleep and respiratory care diagnostics software, to expand its upstream sleep management capabilities and better connect diagnosis workflows with ResMed's treatment ecosystem. ResMed plans to retain Somnoware staff, integrate the platform into its solution portfolio while keeping it open and device-agnostic, and did not disclose material financial terms.
-
Vestar Capital Partners Invests Growth Capital in Nox Health
November 30, 2022
Healthcare Services
Vestar Capital Partners has made a strategic growth investment in Nox Health to accelerate development of the company's sleep diagnostic technology and expand adoption of its value-based sleep management solutions among employers and health plans. Financial terms were not disclosed; the investment will support product and service development and broader market expansion.
-
Omada Health Acquires Physera
May 19, 2020
Healthcare Services
Omada Health has acquired Physera, a digital musculoskeletal (MSK) care provider, to add virtual physical therapy and MSK management to Omada’s suite of digital chronic-care programs. Omada raised growth capital from Perceptive Advisors to finance the acquisition and accelerate integration of Physera’s telehealth and digital exercise therapy capabilities into its offerings for employers, health plans, and consumers.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.